1[2]Ilkova H,Galser B,Tunekale A,et al.Induction of longterm glyee·mi control newly diagnosed type 2 diabedc patients by transientintensive insulin treatment[J].Diabe Care 1997;20(9):1353-1356.
2[3]Ilkova H,Glaser B,Tunkah A,et al.Induction of longterm glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.Diabetes Care 1997;20(9):1353-1356.
5[6]Jankovec Z,Cechurova D,Krcma M,et al.National Register of patients with insulin pump treatment in the Czech Republic.Diabetes Research and Clinical Practice 2006,(74):135-139.
6[7]Hammond P,Boardman S,Greenwood R.ABCD position paper on insulin pumps.Practical Diabetes Int 2006;23(9):395-400.
7[8]Danne T,von Schutz W,Lange K,et al.Current practice of insulin pump the rapy in children and adolescents the Hannovet recipe.Pediatric Diabetes 2006;7(4):25-31.
8[9]Hanas R,Ludvigsson J.Hypoglycemia and ketoacidosis with insulin pump theraw in children and adolescents.Pediattic Diabetes 2006;7(4):32-38.
9[15]Renard E,Costalat G.Closed loop instdin dellvery using implanted insulin pumps and sensor8 in type 1 diabetic patients.Diabetes Research and Clinical Practice 2006;(74):173-177.
10[16]Shalitin S,Phillip M.Closing the loop:combining insulin pumps and glucoses sensors in children with type 1 diabetes mellitus.Pediatric Diabetea 2006;7(4):45-49.
二级参考文献16
1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.
9Stratton IM,Adler AI,Neil HA,et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes(UKPDS 35):Prospective observational study[J].Br Med J,2000,321:405-412.
10Alvarsson M,Sundkvist G,Lager I,et al.Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabieic patients[J].Diabetes Care,2003,26:2 231-2 237.
